They contribute to long-term post-transplant tolerance and prevention of progression to chronic GVHD by limiting T-cell proliferation and downregulation of pro-inflammatory cytokines, while maintaining CD8+ T-cell anti-leukemia activity. The gene discussed is CD8A; the disease is chronic graft versus host disease.